Skip to content

Homecoming Line: Telephone Support for Veterans

Homecoming Line: Telephone Support for Veterans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02655991
Acronym
HCL
Enrollment
358
Registered
2016-01-14
Start date
2008-03-31
Completion date
2014-08-31
Last updated
2016-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Disorders, Post-Traumatic

Keywords

Stress Disorders, Post-Traumatic, Ambulatory Care, Telemedicine, Remote Consultation, Health Services Accessibility

Brief summary

This study will determine whether telephone support improves clinical outcomes of veterans who begin outpatient treatment for posttraumatic stress disorder. Participants will be randomly assigned to receive either usual care or usual care supplemented by biweekly monitoring and support by telephone during the first 3 months of treatment. Patients in both conditions will be compared on PTSD symptoms, engagement in treatment, violence and drinking at 4 months and 12 months after entering treatment.

Detailed description

This multisite randomized controlled trial will test whether a 3-month period of providing telephone monitoring to PTSD patients as a supplement to usual specialty mental health care improves 12-month clinical outcomes (a reduction in PTSD symptoms, violence, and substance use). Secondarily, this study will determine whether telephone monitoring promotes better engagement in outpatient treatment (Number of mental health and psychotherapy visits during the 3-month intervention period). Demand for VA PTSD treatment is increasing as troops return from combat deployments in Afghanistan and Iraq. Telemedicine is likely to be an important component in developing more effective and efficient models of PTSD care that improves patient functioning and treatment utilization. It is hoped that using telephone case monitoring as an inexpensive adjunct to standard care may improve clinical outcomes and reduce hospitalization among veterans with PTSD.

Interventions

Outpatient mental health treatment as usual (normal case management, psychotherapy and/or pharmacotherapy) augmented by up to six fortnightly telephone monitoring and support calls from a case manager during the first three months of treatment.

BEHAVIORALTreatment as Usual

Outpatient mental health treatment as usual (normal case management, psychotherapy and/or pharmacotherapy).

Sponsors

Durham VA Medical Center
CollaboratorFED
VA Puget Sound Health Care System
CollaboratorFED
VA Palo Alto Health Care System
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* VA patients newly entering outpatient treatment mental health treatment for PTSD starting a new phase of outpatient PTSD treatment (e.g., transitioning from a psycho-education group to active psychotherapy) at one of the study sites.

Exclusion criteria

* Active duty personnel * Cognitive impairment which precludes giving informed consent * Initiating residential or inpatient treatment rather than outpatient treatment

Design outcomes

Primary

MeasureTime frameDescription
PTSD Checklist (PCL) Slope12 monthsSlope of improvement on the PTSD Checklist, a self-report measure of PTSD symptoms.

Secondary

MeasureTime frameDescription
Other mental health visits - intervention period3 monthsNumber of other mental health visits (mental health visits without psychotherapy procedure code and/or without a PTSD diagnosis code) completed during the 3 month intervention period.
Depression slope12 monthsSlope of improvement on the Center for Epidemiological Studies Scale, a self-report measure of depression symptoms.
Alcohol problems slope12 monthsSlope of improvement on the Addiction Severity Index Alcohol Composite, a self-report measure of alcohol-related problems.
Drug problems slope12 monthsSlope of improvement on the Addiction Severity Index Drug Composite, a self-report measure of drug-related problems.
Aggression slope12 monthsSlope of improvement on a six-item self-report measure of aggressive behaviors, adapted from the Conflict Tactics Scale.
PTSD psychotherapy visits - intervention period3 monthsNumber of psychotherapy visits for PTSD (psychotherapy procedure code + PTSD diagnosis code) completed during the 3 month intervention period.
PTSD psychotherapy visits -- follow-up periodmonths 4-12Number of psychotherapy visits for PTSD (psychotherapy procedure code + PTSD diagnosis code) completed during the post-intervention period (months 4-12).
Other mental health visits -- follow-up periodmonths 4-12Number of other mental health visits (mental health visits without psychotherapy procedure code and/or without a PTSD diagnosis code) completed during the post-intervention period (months 4-12).
Selective serotonin reuptake inhibitor refills (medication possession ratio)12 monthsNumber of days' supply of selective serotonin reuptake inhibitors (SSRIs) obtained divided by 365 days.
Prazosin refills (medication possession ratio)12 monthsNumber of days' supply of Prazosin obtained divided by 365 days.
Quality of Life slope12 monthsSlope of improvement on a self-report quality measure used in the Veterans Affairs Military Stress Treatment Assessment study.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026